Table 2.
The correlation of LATS1 and YAP expression with clinicopathological characteristics of LAC patients
| Variables | Cases (n) | LATS1 | P | YAP | P | ||
|---|---|---|---|---|---|---|---|
| − | + | − | + | ||||
| Total | 75 | 55 | 20 | 18 | 57 | ||
| Age (years) | |||||||
| ≥60 | 40 | 32 | 8 | 0.166 | 7 | 33 | 0.162 |
| <60 | 35 | 23 | 12 | 11 | 24 | ||
| Gender | |||||||
| Male | 40 | 31 | 9 | 0.386 | 13 | 27 | 0.067 |
| Female | 35 | 24 | 11 | 5 | 30 | ||
| Tumour size (cm) | |||||||
| ≥5 | 44 | 33 | 11 | 0.699 | 12 | 32 | 0.432 |
| <5 | 31 | 22 | 9 | 6 | 25 | ||
| Pathological stage | |||||||
| I + II | 62 | 45 | 17 | 0.749 | 13 | 49 | 0.182 |
| III | 13 | 10 | 3 | 5 | 8 | ||
| TNM stage | |||||||
| T1 + T2 | 62 | 47 | 15 | 0.293 | 15 | 47 | 0.932 |
| T3 | 13 | 8 | 5 | 3 | 10 | ||
| Lymph node metastasis | |||||||
| Negative | 35 | 21 | 14 | 0.015 | 14 | 21 | 0.003 |
| Positive | 40 | 34 | 6 | 4 | 36 | ||